AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline - December 6, 2023
AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases - September 19, 2023
BlueWhale Bio Founded with $18M Financing led by Danaher Ventures to Accelerate Cell Therapy Manufacturing - September 7, 2023
Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures - June 27, 2023
Telesis Bio Secures Financing of $28.0 Million - May 31, 2023
Mercy BioAnalytics Raises $41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection - April 3, 2023
Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp. - February 9, 2023
LevitasBio Completes Series C Financing Led by Novalis Lifesciences - November 7, 2022
mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA - August 23, 2022
Animol Discovery, Inc. Announces Series B Financing of $34.0 million to Advance Its Pipeline of Novel Veterinary Pharmaceuticals - July 28, 2022
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing - March 8, 2022
Ori Biotech Raises Over $100 million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform - January 18, 2022
SkylineDx Raises New Capital from Novalis LifeSciences and Van Herk Investments - December 21, 2021
Novalis LifeSciences Launches its Second Life Science Investment Fund with $300M and Announces Key New Team Members - December 8, 2021
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds - September 14, 2021
Biotalys Announces Successful €54.6 Million Initial Public Offering - July 1, 2021
Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker “QSI” on Nasdaq Stock Exchange - June 10, 2021
Vizgen Secures $37M Series B Financing to Advance Spatial Genomics Through Commercialization of MERSCOPE™ Platform - April 7, 2021
Veracyte Completes Acquisition of Decipher Biosciences - March 15, 2021
Cerevel Therapeutics Debuts as Publicly Traded Neuroscience Company - October 28, 2020
Enko Launches with $66 Million in Funding to Deliver Products that Enable Farmers to Protect Crops From Pests and Disease - June 26, 2020
Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider - April 9, 2020
Obesity-Focused Allurion Scoops Up $34M in New Funding - January 8, 2020
Novalis LifeSciences Launches its First Life Science Investment Fund with $85 Million - August 20, 2019
Ginkgo Bioworks Appoints Former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors - April 16, 2019
Cerevel Therapeutics Expands its Board of Directors - December 20, 2018
Quanterix Corporation Announces Closing of Initial Public Offering - December 11, 2017